These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 1773301)
21. Oxybutinin and the prevention of urinary incontinence in spina bifida. Hehir M; Fitzpatrick JM Eur Urol; 1985; 11(4):254-6. PubMed ID: 3899664 [TBL] [Abstract][Full Text] [Related]
26. The use of salivary stimulant pastilles to improve compliance in women taking oxybutynin hydrochloride for detrusor instability: a pilot study. Hooper P; Tincello DG; Richmond DH Br J Urol; 1997 Sep; 80(3):414-6. PubMed ID: 9313659 [TBL] [Abstract][Full Text] [Related]
27. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia. O'Flynn KJ; Thomas DG Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538 [TBL] [Abstract][Full Text] [Related]
29. Effect of oxybutynin on the QTc interval in elderly patients with urinary incontinence. Hussain RM; Hartigan-Go K; Thomas SH; Ford GA Br J Clin Pharmacol; 1996 Jan; 41(1):73-5. PubMed ID: 8824696 [TBL] [Abstract][Full Text] [Related]
33. Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Yarker YE; Goa KL; Fitton A Drugs Aging; 1995 Mar; 6(3):243-62. PubMed ID: 7620236 [TBL] [Abstract][Full Text] [Related]
34. Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability. Halaska M; Ralph G; Wiedemann A; Primus G; Ballering-Brühl B; Höfner K; Jonas U World J Urol; 2003 May; 20(6):392-9. PubMed ID: 12811500 [TBL] [Abstract][Full Text] [Related]
35. Oxybutynin and intranasal desmopressin for clozapine-induced urinary incontinence. Lurie SN; Hosmer C J Clin Psychiatry; 1997 Sep; 58(9):404. PubMed ID: 9378693 [No Abstract] [Full Text] [Related]
36. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder. Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832 [TBL] [Abstract][Full Text] [Related]
37. [Treatment with oxybutynin hydrochloride of urinary incontinence and hyperactive bladder conditions in children]. Aubert D; Cencig P; Royer M Ann Pediatr (Paris); 1986 Sep; 33(7):629-34. PubMed ID: 3777773 [No Abstract] [Full Text] [Related]
38. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study]. Enzelsberger H; Kurz C; Helmer H; Mittermayer F Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378 [TBL] [Abstract][Full Text] [Related]
39. [Combination of oxybutynin chloride (Ditropan) with intermittent catheterization in the treatment of neurogenic bladder in childhood: results on continence]. De Castro R; Casolari E; Ricci S Pediatr Med Chir; 1984; 6(6):795-803. PubMed ID: 6545593 [TBL] [Abstract][Full Text] [Related]
40. Trospium chloride and oxybutynin hydrochloride in a german study of adults with urinary urge incontinence: results of a 12-week, multicenter, randomized, double-blind, parallel-group, flexible-dose noninferiority trial. Zellner M; Madersbacher H; Palmtag H; Stöhrer M; Bödeker RH; Clin Ther; 2009 Nov; 31(11):2519-39. PubMed ID: 20109997 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]